Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).
Saved in:
| Title: | Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC). |
|---|---|
| Authors: | Fernandez-Martinez, A.1,2 (AUTHOR), Tanioka, M.3 (AUTHOR), Ahn, S.G.4 (AUTHOR), Zagami, P.1,5 (AUTHOR), Pascual, T.6,7,8,9 (AUTHOR), Rediti, M.10 (AUTHOR), Tang, G.11,12 (AUTHOR), Hoadley, K.A.1,2 (AUTHOR), Venet, D.10 (AUTHOR), Rashid, N.U.1,13 (AUTHOR), Spears, P.A.1 (AUTHOR), Di Cosimo, S.14 (AUTHOR), de Azambuja, E.15 (AUTHOR), Choudhury, A.16 (AUTHOR), Rastogi, P.11,17 (AUTHOR), Islam, M.N.18 (AUTHOR), Cortes, J.19,20,21,22 (AUTHOR), Llombart-Cussac, A.23 (AUTHOR), Swain, S.M.11,24 (AUTHOR), Sotiriou, C.10 (AUTHOR) |
| Source: | Annals of Oncology. Apr2025, Vol. 36 Issue 4, p403-413. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.12.010 |
